Hoyos, C. (2022). L’inhibition HDAC induite par le valproate améliore la cytotoxicité directe des monocytes contre les cellules de mésothéliome pleural malin. Unpublished doctoral thesis, ULiège - Université de Liège [Gembloux Agro Bio-Tech], Gembloux, Belgium. Jury: Willems, L. (Promotor), Jacques, P., Arnaud Scherpereel, Christophe Blanquart, Schroyen, M., ... CATALDO, D. |
Hoyos, C.* , Fontaine, A.* , Jacques, J.-R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Jamakhani, M.* , Hamaïdia, M.* , & Willems, L.*. (26 April 2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14 (9), 2164. doi:10.3390/cancers14092164 * These authors have contributed equally to this work. |
Hoyos, C. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma. Paper presented at Giga Cancer Day, Liège, Belgium. |
Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma. Poster session presented at Giga Cancer Day, Liège, Belgium. * These authors have contributed equally to this work. |
Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (27 June 2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211 |
Hoyos, C. (26 March 2021). The contribution of hdac inhibition in therapy of malignant pleural mesothelioma. Paper presented at Séminaire du Giga-Cancer, Liège, Belgium. |
Hoyos, C., Hamaïdia, M., Safari, R., & Willems, L. (28 November 2019). Les monocytes possèdent une activité cytotoxique directe envers les cellules de mésothéliome pleural malin. Poster session presented at 2n des Journées Francophones du Mésothéliome (Nantes), Nantes, France. |
Hoyos, C. (19 November 2019). L'inhibition de PD-1 augmente l'activité cytotoxique des macrophages envers les cellules de mésothéliome pleural malin. Paper presented at 2e des Journées Francophones du Mésothéliome. |
Abdala, A., Alvarez, I., Brossel, H., Calvinho, L., Carignano, H., Franco, L., Gazon, H., Gillissen, C., Hamaïdia, M., Hoyos, C., Jacques, J.-R., Joris, T., Laval, F., Petersen, M., Porquet, F., Porta, N., Ruiz, V., Safari, R., Suárez Archilla, G., ... Willems, L. (07 October 2019). BLV: lessons on vaccine development. Retrovirology, 2019 (16), 26. doi:10.1186/s12977-019-0488-8 |
Hamaïdia, M., Gazon, H., Hoyos, C., Hoffmann, G. B., Louis, R., DUYSINX, B., & Willems, L. (2019). Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. JCI Insight, 4 (18). doi:10.1172/jci.insight.128474 |
Hoyos, C., Hamaïdia, M., Black, I., DUYSINX, B., LOUIS, R., & Willems, L. (28 May 2018). Immunoediting activity of macrophages against mesothelioma cells. Poster session presented at Séminaire de l'EDT-Immunologie, Liège, Belgium. |
Gazon, H., Chauhan, P. S., Hamaïdia, M., Hoyos, C., Li, L., Safari, R., & Willems, L. (15 January 2018). How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response? Frontiers in Microbiology, 8, 2684. doi:10.3389/fmicb.2017.02684 |